Advertisement
According to this report, entitled MedPredict Thought Leader Insight &Analysis: Women's Health, physician experts in North America and Europe seevasomotor symptoms, female sexual dysfunction, and breast care prevention asthe hottest topics in Women's Health pharmaceutical research today.
Advertisement
Vasomotor symptoms (hot flush, hot flash, night sweats) are extremelyprevalent in perimenopausal and menopausal women, with report ratesapproaching 90%. This report explores the emerging standards of care fortreating these symptoms, including both hormonal and non-hormonalpharmacotherapies.
Following the FDA's high profile 2004 rejection of P&G's Intrinsa forfemale sexual dysfunction (FSD) due to safety concerns, the pharmaceuticalindustry has been cautious about proceeding with clinical programs fortestosterone-based therapies. MedPredict's expert panel weighs in on therisks and benefits of such therapies, as well as exploring new endpoints theythink are relevant to FSD but are being overlooked by pharmaceuticaldevelopers.
While there are a number of SERMs (selective estrogen receptor modulators)either approved or in clinical development for the prevention of breastcancer, MedPredict's research shows leading physicians are ambivalent tonegative in their interest in this class of drugs for this indication."Breast cancer is coming to be considered as a curable disease for many women(metastatic breast cancer not withstanding), according to MedPredict PresidentJeffrey D. Berk, PhD. "SERMs are lumped in with aromatase inhibitors when ourphysician panel considers the possible long-term adverse effects vs. the realpotential to increase survival and quality of life."
This report can be purchased by contacting MedPredict. Members of themedia may request an interview.
About MedPredict
MedPredict (http://www.medpredict.com) maintains a proprietary database ofover 1,000 global physician thought leaders, including 40+ specialties in 30+therapeutic categories. Based on primary interviews with these thoughtleaders, we publish periodic reports in each category to keep our clientsup-to-date on emerging trends and competitive activity. The reports includethought leader reactions to recent publications and medical conferences, aswell as clinical, regulatory and marketing activity.
SOURCE MedPredict
